Search Results - steven+dubinett

2 Results Sort By:
Gene-Modified Conventional Type 1 Dendritic Cells (UCLA Case No. 2026-093)
UCLA researchers in the Departments of Medicine and Pulmonary Disease have recently developed a novel approach for improving the long-term efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer. BACKGROUND: Non-small cell lung cancer (NSCLC) is one of the most common types of lung cancer. Anti-PD-1 immunotherapy is used for treatment despite...
Published: 5/16/2026   |   Updated: 3/4/2026   |   Inventor(s): Bin Liu, Steven Dubinett
Keywords(s):  
Category(s): Therapeutics > Oncology, Therapeutics > Gene Therapy And Editing, Therapeutics > Vaccines
Combination Immunotherapy (UCLA Case No. 2015-348)
Combination ImmunotherapySUMMARYUCLA researchers have developed a combination immunotherapy for lung cancer that functions by evoking anti-tumor immune responses in lung cancer patients.BACKGROUNDLung cancer is a challenging health problem, claiming more than 1.1 million deaths worldwide annually. Despite incredible medical progress, the long-term survival...
Published: 12/2/2025   |   Updated: 8/28/2019   |   Inventor(s): Jay Lee, Steven Dubinett, Sherven Sharma
Keywords(s): Immunotherapy, Oncology Immunotherapy, Therapeutics & Vaccines
Category(s): Therapeutics, Therapeutics > Immunology And Immunotherapy, Therapeutics > Oncology > Oncology Immunotherapy